Home » Analyst Articles – US
Immix Biopharma (NASDAQ:IMMX) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Immix Biopharma (NASDAQ:IMMX – Get Free Report) had its price target increased by stock analysts at Morgan Stanley from $20.00 to $21.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The... More of this article »
Bally’s (NYSE:BALY) Stock Price Target Cut by Truist Financial
Bally’s (NYSE:BALY – Get Free Report) had its target price cut by stock analysts at Truist Financial from $10.00 to $9.00 in a report released on Wednesday, Marketbeat reports. The brokerage presently has a “hold”... More of this article »
Morgan Stanley Upgrades CNX Resources (NYSE:CNX) to Equal Weight
CNX Resources (NYSE:CNX – Get Free Report) was upgraded by equities research analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating in a research note issued to investors on... More of this article »
Guggenheim Has Lowered Expectations for Dutch Bros (NYSE:BROS) Stock Price
Dutch Bros (NYSE:BROS – Get Free Report) had its price target dropped by equities research analysts at Guggenheim from $76.00 to $62.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy”... More of this article »
Barclays Forecasts Strong Price Appreciation for Cardinal Health (NYSE:CAH) Stock
Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by investment analysts at Barclays from $275.00 to $320.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an “overweight”... More of this article »
Royal Bank Of Canada Reaffirms “Sector Perform” Rating for Builders FirstSource (NYSE:BLDR)
Builders FirstSource (NYSE:BLDR – Get Free Report)‘s stock had its “sector perform” rating reissued by equities researchers at Royal Bank Of Canada in a report released on Wednesday, Benzinga reports. They currently... More of this article »
CMB.TECH (NYSE:CMBT) Upgraded at Dnb Carnegie
Dnb Carnegie upgraded shares of CMB.TECH (NYSE:CMBT – Free Report) from a hold rating to a strong-buy rating in a research report report published on Tuesday,Zacks reports. A number of other equities research analysts have also... More of this article »
BTIG Research Issues Pessimistic Forecast for Salesforce (NYSE:CRM) Stock Price
Salesforce (NYSE:CRM – Get Free Report) had its price target decreased by analysts at BTIG Research from $300.00 to $250.00 in a report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating... More of this article »
BP (NYSE:BP) Upgraded at Kepler Capital Markets
Kepler Capital Markets upgraded shares of BP (NYSE:BP – Free Report) from a hold rating to a strong-buy rating in a report released on Tuesday,Zacks reports. BP has been the subject of several other research reports. TD Cowen... More of this article »
Citigroup Forecasts Strong Price Appreciation for JD.com (NASDAQ:JD) Stock
JD.com (NASDAQ:JD – Get Free Report) had its target price increased by Citigroup from $39.00 to $44.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the information services... More of this article »
Citigroup Has Lowered Expectations for NET Power (NYSE:NPWR) Stock Price
NET Power (NYSE:NPWR – Get Free Report) had its target price dropped by analysts at Citigroup from $3.50 to $3.20 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating... More of this article »
Tyson Foods (NYSE:TSN) Stock Price Expected to Rise, Bank of America Analyst Says
Tyson Foods (NYSE:TSN – Get Free Report) had its price target raised by equities research analysts at Bank of America from $56.00 to $65.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “neutral”... More of this article »
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Target Cut by Barclays
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report) had its target price reduced by analysts at Barclays from $14.00 to $10.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has an “overweight”... More of this article »
Wolfe Research Begins Coverage on Monster Beverage (NASDAQ:MNST)
Stock analysts at Wolfe Research began coverage on shares of Monster Beverage (NASDAQ:MNST – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The firm set an “outperform” rating on the... More of this article »
Keefe, Bruyette & Woods Has Lowered Expectations for Oaktree Specialty Lending (NASDAQ:OCSL) Stock Price
Oaktree Specialty Lending (NASDAQ:OCSL – Get Free Report) had its price target dropped by Keefe, Bruyette & Woods from $13.50 to $12.50 in a research report issued to clients and investors on Wednesday, Marketbeat Ratings... More of this article »
Robert W. Baird Forecasts Strong Price Appreciation for Midera Food Processing (NASDAQ:MFP) Stock
Midera Food Processing (NASDAQ:MFP – Get Free Report) had its price objective upped by equities researchers at Robert W. Baird from $40.00 to $43.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a... More of this article »
Micron Technology (NASDAQ:MU) Stock Rating Reaffirmed as Outperform by Royal Bank Of Canada
Micron Technology (NASDAQ:MU – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Royal Bank Of Canada in a research note issued on Wednesday, MarketBeat.com reports.... More of this article »
BTIG Research Reaffirms “Buy” Rating for MARA (NASDAQ:MARA)
MARA (NASDAQ:MARA – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at BTIG Research in a research note issued on Wednesday, Benzinga reports. They currently have a $27.00 target... More of this article »
Lantern Pharma (NASDAQ:LTRN) Stock Gets Downgrade from Rodman & Renshaw
Lantern Pharma (NASDAQ:LTRN – Get Free Report) was downgraded by equities researchers at Rodman & Renshaw from a “buy” rating to a “neutral” rating in a report released on Wednesday, Marketbeat.com... More of this article »
uniQure (NASDAQ:QURE) Stock Price Target Cut by HC Wainwright
uniQure (NASDAQ:QURE – Get Free Report) had its price target cut by stock analysts at HC Wainwright from $80.00 to $65.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy”... More of this article »
Qualcomm (NASDAQ:QCOM) Stock Price Target Cut by Robert W. Baird
Qualcomm (NASDAQ:QCOM – Get Free Report) had its price objective cut by equities researchers at Robert W. Baird from $320.00 to $300.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently... More of this article »
Praxis Precision Medicines (NASDAQ:PRAX) Upgraded at Wells Fargo & Company
Wells Fargo & Company upgraded shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) from an equal weight rating to an overweight rating in a research note published on Tuesday morning, MarketBeat Ratings reports.... More of this article »
HC Wainwright Reaffirms “Buy” Rating for Prelude Therapeutics (NASDAQ:PRLD)
Prelude Therapeutics (NASDAQ:PRLD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports. They... More of this article »
